🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
12/05/2015 0,7900 USD
10/02/2015 0,7900 USD
10/11/2014 0,6100 USD
12/08/2014 0,6100 USD
13/05/2014 0,6100 USD
11/02/2014 0,6100 USD
12/11/2013 0,4700 USD
14/08/2013 0,4700 USD
14/05/2013 0,4700 USD
11/02/2013 0,4700 USD
13/11/2012 0,3600 USD
14/08/2012 0,3600 USD
14/05/2012 0,3600 USD
13/02/2012 0,3600 USD
15/11/2011 0,2800 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/01/2011 57,21 57,43 56,60 56,98 -0,54% 1,45% 5.771.500
18/01/2011 56,40 57,34 56,35 57,29 +1,40% 1,76% 10.611.900
14/01/2011 56,05 57,28 56,05 56,50 +0,32% 2,19% 5.893.700
13/01/2011 56,72 57,00 56,23 56,32 -0,93% 1,36% 4.660.300
12/01/2011 56,30 56,92 56,05 56,85 +1,17% 1,55% 4.566.400
11/01/2011 56,55 56,88 56,09 56,19 -0,44% 1,40% 5.863.900
10/01/2011 56,47 56,95 56,21 56,44 -0,95% 1,31% 4.758.900
07/01/2011 56,50 57,19 56,46 56,98 +0,76% 1,29% 4.680.800
06/01/2011 56,68 57,18 56,07 56,55 -0,32% 1,96% 3.561.400
05/01/2011 56,46 57,16 56,40 56,73 -0,04% 1,35% 4.552.000
04/01/2011 55,77 57,24 55,69 56,75 +2,16% 2,78% 8.429.500
03/01/2011 55,20 56,28 55,18 55,55 +1,18% 1,99% 5.453.300
31/12/2010 55,47 55,61 54,77 54,90 -1,13% 1,51% 3.997.500
30/12/2010 55,69 56,17 55,46 55,53 -0,61% 1,27% 3.414.000
29/12/2010 56,15 56,37 55,87 55,87 -0,16% 0,89% 3.601.700
28/12/2010 56,38 56,56 55,94 55,96 -0,85% 1,10% 4.025.200
27/12/2010 56,53 56,67 56,01 56,44 -0,48% 1,17% 2.758.400
23/12/2010 56,70 57,07 56,46 56,71 -0,42% 1,08% 4.074.800
22/12/2010 57,20 57,37 56,63 56,95 -0,77% 1,29% 4.411.800
21/12/2010 57,57 57,70 57,17 57,39 -0,45% 0,92% 5.598.000
20/12/2010 57,56 57,98 57,44 57,65 +0,40% 0,94% 6.980.600
17/12/2010 57,00 57,90 56,58 57,42 +1,40% 2,32% 21.618.900
16/12/2010 55,70 56,80 55,64 56,63 +1,72% 2,08% 12.950.800
15/12/2010 56,53 56,95 55,35 55,67 -1,92% 2,83% 14.247.900
14/12/2010 56,45 57,22 55,24 56,76 +4,90% 3,51% 23.617.700
13/12/2010 53,94 54,34 53,85 54,11 +0,41% 0,91% 5.523.100
10/12/2010 53,32 54,00 53,29 53,89 +0,92% 1,33% 6.567.800
09/12/2010 53,31 53,58 53,10 53,40 +0,23% 0,90% 4.701.300
08/12/2010 53,04 53,55 53,00 53,28 +0,28% 1,04% 4.666.400
07/12/2010 53,62 53,72 52,98 53,13 -0,51% 1,38% 5.837.200